Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial update describes combination chemotherapy for patients with recurrent or refractory leukemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED